Compare Hims and Hers Health Inc (HIMS) vs Nasdaq100 ETF (QQQ) Price & Performance

Hims & Hers Health trades at $32.70, down 0.43% on the day, with a bearish technical signal despite bullish moving averages. The company reported $2.35 billion in 2025 revenue but swung to a projected net loss for 2026, with mixed quarterly earnings results. Recent news highlights executive changes and anticipation for Q2 2026 results on August 10, 2026, with analyst sentiment leaning toward a Buy consensus.

The outlook is cautious due to profitability concerns and high valuation multiples, but growth opportunities in weight-loss and telehealth services offer potential. Key risks include execution challenges and regulatory scrutiny. The stock presents a speculative growth play with a consensus price target of $33.57, slightly above the current price.

QQQ trades at $696.06, up 0.1% on the day, with technical indicators showing a bearish trend amid neutral oscillators. The ETF faces mixed analyst sentiment with a 50% buy and 50% sell consensus. Recent news highlights concentration in big tech and institutional position adjustments, while a future dividend of $0.81 is scheduled for July 2026.

Outlook remains cautious due to technical bearishness and divided analyst views. Key risks include tech sector volatility and macroeconomic factors influencing rate decisions. Upside potential hinges on sustained AI-driven growth, but investors should weigh concentration risks in Nasdaq-100 holdings.